Doliente, Luzviminda B.
HRN: 00-57-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2024
CEFIXIME 200MG (CAP)
08/28/2024
09/04/2024
PO
200mg
Q12
CAP MR
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes